Mark Cuban, the tech titan, Dallas Mavericks proprietor, and star of ABC’s Shark Tank, strikes by the world like a pleasant nice white, all enamel and eyes and relentless movement. Once we meet on an October morning at his workplace within the Mavericks’ headquarters, the serial entrepreneur, 64, is sporting a long-sleeved T-shirt promoting his final funding: Mark Cuban Value Plus Drug Co. I used to be there to search out out why a man who’s made billions in tech, gained an NBA championship, and turn out to be maybe the preferred businessman on actuality TV was spending his time and fortune hawking generic anti-fungal drugs on-line for $7.34.
“To f–ok issues up,” Cuban explains. “That’s what capitalism is all about. Capitalism isn’t simply, ‘All people ought to make as a lot cash as they’ll.’ Capitalism is about discovering options to issues and seeing what you are able to do to unravel them.”
Value Plus Medicine, which launched in January, is Cuban’s try and show that disruption is usually a type of benevolence. The for-profit on-line pharmacy goals to undercut the well being care business by promoting generic medicine for the whole lot from bronchial asthma to glaucoma to rheumatoid arthritis for a fraction of the standard value. Cuban likes to say that the corporate’s actual product is transparency: in an business the place hospitals can promote most cancers medicine at a 600% markup, Value Plus sells generic drugs for the price of manufacturing them, plus a 15% markup and transport charges. The purpose, says Cuban, is to turn out to be the most important low-cost supplier of remedy in America.
Although Cuban gained’t say precisely how a lot of the corporate he owns, he calls the brand new on-line pharmacy a win-win. If established pharmacies maintain charging sufferers artificially excessive costs, Value Plus might emerge as a preferred low-cost various. If the business slashes shopper costs to compete, he’ll have nearly single-handedly introduced reform to an business that stubbornly resists it. “The incumbents may come alongside and duplicate us, get a coronary heart, get a conscience,” Cuban says. “That might be OK.”
For many years, politicians have been promising to cut back the price of prescribed drugs, and for many years, they’ve largely failed. To Cuban, the persistent incapability to deal with runaway drug pricing has bolstered his dim view of the political system’s means to unravel massive issues. He not solely believes the well being care system is damaged. He additionally thinks American authorities is just too messed as much as repair it.
For a man who expresses himself by property and acquisitions (plus the occasional podcast episode), Value Plus Medicine represents a billionaire’s seek for that means in a world that’s more and more skeptical of the ability of the über-rich. Cuban’s counterparts within the 0.01% have turn out to be political megadonors, began world foundations, turn out to be patrons of the humanities and humanities. He prefers to construct his legacy the best way he’s constructed his fortune: by entrepreneurship. Value Plus Medicine is a sort of center path between progressive reform and philanthropic giving, one which goals to disrupt predatory markets as a means of regulating them.
The enterprise has a protracted option to go to upend the $1.4 trillion pharmaceutical business. Value Plus Medicine presents about 1,000 drugs within the U.S.—a small fraction of the medicine accessible—and doesn’t but take most insurance coverage, though Cuban says that can change in 2023. Whereas some prospects say Value Plus has lowered their medical payments, it’s too early to inform whether or not the mannequin can scale. “Mark Cuban has managed to disrupt a really small slice of the well being care system,” says Larry Levitt, govt vp on the nonpartisan health-coverage group KFF, who referred to as out-of-pocket generic medicine the “low-hanging fruit” of the system. “It stays to be seen whether or not he can work out a option to increase that slice.”
Cuban’s e mail handle is publicly accessible, and tons of of funding pitches land in his inbox each week. He reads the primary paragraph and deletes them 99% of the time, he says. However in 2018, Cuban bought a chilly e mail from Dr. Alex Oshmyansky, a radiologist, asking if he would think about investing in an organization that sells generic drugs for roughly the price of manufacturing. He responded inside 5 minutes. “The extra questions I requested him concerning the drug aspect of issues,” Cuban says, “the extra apparent it was that there was a chance there.”
You may not count on that an entrepreneur as buzzy as Cuban could be drawn to the world of generic prescription drugs. However lengthy earlier than Oshmyansky’s e mail landed in his inbox, Cuban had been within the inefficiencies within the well being care business. He had taken word of the controversy surrounding “pharma bro” Martin Shkreli, who in 2015 jacked up the value of Daraprim, a lifesaving antiparasitic drug, from $13.50 to $750 per capsule. “If the pharma bro can jack up costs, that signifies that there’s some distortion of pricing,” Cuban says. “And there should be a option to cut back them the identical means.” Watching President Trump and congressional Republicans work to remove the Inexpensive Care Act with no viable alternative, he provides, satisfied him that the two-party system was not properly outfitted to deal with well being care.
Cuban pushed Oshmyansky, who launched the corporate as a nonprofit in 2015, to show the enterprise right into a for-profit firm, arguing it could be extra sustainable if it weren’t reliant on fundelevating. His fortune has created a protracted runway, and his fame has allowed him to unfold the phrase about an enterprise that may have in any other case languished in obscurity. “It’s not even a lot Mark’s capital. It’s his superstar that has been the magic key that’s unlocked plenty of this,” says Oshmyansky. “Mark’s platform is definitely way more precious than the capital he’s capable of present.”
The corporate has had some rising pains. Its employees of 33 has struggled to maintain up with skyrocketing demand, even because the menu of medication the corporate presents stays restricted. (Promoting every drug requires advanced negotiations with producers and regulators, and Value Plus Medicine doesn’t but supply drugs like insulin, misoprostol, or epinephrine auto-injectors for peanut allergic reactions.) They’re constructing a producing plant close to its Dallas headquarters to make medicine on-site, but it surely gained’t be completed for months. Some prospects have complained that their drugs take too lengthy to reach, or that customer support is gradual. Cuban says these are the rising pains of a bare-bones crew making an attempt to serve greater than 1.3 million accounts.
Different prospects say that Value Plus has already helped them. Andrew Hums, a 37-year-old auto salesman in Pennsylvania, says he saved greater than $600 on a three-month prescription for an assortment of diabetes and blood-stress remedy. “That’s greater than a automotive cost for most individuals,” he says. “For some folks, that’s lease.”
Cuban, who’s price an estimated $4.6 billion, says he’s not in it to “make my subsequent greenback.” Neither is he excited about a run for political workplace, regardless of the long-standing rumors. “That’s the one factor I do know I’d suck at,” he says. As a substitute, Value Plus Medicine is a part of a playbook to make use of his fortune for a brand new sort of benevolent disruption. “I may go on to the subsequent factor, and the subsequent factor and the subsequent factor,” he says. “However it wouldn’t be as a politician; it could be as a capitalist.”
Extra Should-Reads From TIME